Undervalued Opportunity in HIMS

2 months ago

Speaker

"The first one is Hems and Hers health. It's down 34% over the last months and people again are doubting the stock and they're kind of crying about it a little bit. But to me, I've been in the stock from $7 per share and people told me, 'I wish I bought him at seven.' The only way I was able to hold from $7 is because I was not paying attention to the chart; I was paying attention to the fundamentals, to the long-term thesis around the company. Most investors can't do it. I still believe he is an undervalued opportunity."

The speaker discusses Hims and Hers health, noting its steep decline and the resulting investor skepticism. Emphasizing a focus on long-term fundamentals over short-term chart movements, the speaker highlights that holding the stock from a $7 entry point was possible due to a strong underlying thesis, ultimately characterizing the stock as an undervalued opportunity.

Related Stocks